Suchergebnisse - "Newgreen, Donald"

PubPharm (163)

1

Skip segment Hirschsprung disease: modelling the trans-mesenteric origin of the enteric nervous system in the human colon

enthalten in: bioRxiv.org | 2022

von Newgreen, D. | Osborne, J. | Zhang, D.

2

A Novel Method for Identifying the Transition Zone in Long-Segment Hirschsprung Disease : Investigating the Muscle Unit to Ganglion Ratio

enthalten in: Biomolecules | 2022

von Yang, W. | Pham, J. | King, S. | +4

3

Twenty Years on for The Epithelial-Mesenchymal Transition International Association (TEMTIA) : An Interview with Co-Founders Erik Thompson and Donald Newgreen

enthalten in: Cells, tissues, organs | 2022

von Sheng, G. | Thompson, E. | Newgreen, D. | +1

4

Author Correction : Guidelines and definitions for research on epithelial-mesenchymal transition

enthalten in: Nature reviews. Molecular cell biology | 2021

von Yang, J. | Antin, P. | Berx, G. | +45

ErratumFor: Nat Rev Mol Cell Biol. 2020 Jun;21(6):341-352. - PMID 32300252

5

The Somatic Mutation Paradigm in Congenital Malformations : Hirschsprung Disease as a Model

enthalten in: International journal of molecular sciences | 2021

von MacKenzie, K. | Garritsen, R. | Chauhan, R. | +15

6

Development of Functional Thyroid C Cell-like Cells from Human Pluripotent Cells in 2D and in 3D Scaffolds

enthalten in: Cells | 2021

von Abu-Bonsrah, K. | Newgreen, D. | Dottori, M.

7

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity

enthalten in: Pharmacology research & perspectives | 2020

von Tannenbaum, S. | den Adel, M. | Krauwinkel, W. | +4

8

RET overactivation leads to concurrent Hirschsprung disease and intestinal ganglioneuromas

enthalten in: Development (Cambridge, England) | 2020

von Nagy, N. | Guyer, R. | Hotta, R. | +5

9

Guidelines and definitions for research on epithelial-mesenchymal transition

enthalten in: Nature reviews. Molecular cell biology | 2020

von Yang, J. | Antin, P. | Berx, G. | +45

ErratumIn: Nat Rev Mol Cell Biol. 2021 Dec;22(12):834. - PMID 34654908

10

Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity : results from two phase 3 prospective open-label studies

enthalten in: Journal of pediatric urology | 2020

von Franco, I. | Hoebeke, P. | Baka-Ostrowska, M. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]